{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:19:43Z","timestamp":1793092783997,"version":"4.5.0"},"reference-count":50,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"unspecified","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104798"],"award-info":[{"award-number":["82104798"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ21H270005"],"award-info":[{"award-number":["LQ21H270005"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhejiang Chinese Medical University school-level research fund project-natural Science Youth Exploration Project","award":["2021JKZKTS018B, 2024JKZKTS20"],"award-info":[{"award-number":["2021JKZKTS018B, 2024JKZKTS20"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2024,10,4]]},"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Hydroxychloroquine (HCQ) is an antimalarial drug employed in the treatment of systemic lupus erythematosus (SLE). Prior studies reported inconsistent results regarding the association between HCQ use during pregnancy and adverse pregnancy outcomes. This study aimed to evaluate the impact of HCQ on pregnancy-related outcomes in women with SLE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a systematic search for studies associating pregnancy outcomes with HCQ use in PubMed, EMBASE, Cochrane Library, Web of Science, CNKI, Wanfang database and VIP from inception to 22 September 2022. Random or fixed effect models were used to estimate the pooled effect based on I\n                      <jats:sup>2<\/jats:sup>\n                      measurement of heterogeneity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-one studies were included, encompassing 929 and 1031 patients in HCQ and non-HCQ groups, respectively. We found that HCQ use was significantly associated with reduced risks of Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) scores (second trimester: mean difference (MD) \u22121.80, 95% CI \u22122.46 to \u20131.13; third trimester: MD \u22122.30, 95% CI \u22123.31 to \u20131.29), flare (OR 0.57, 95% CI 0.33 to 0.97), preterm birth (OR 0.57, 95% CI 0.46 to 0.72), intrauterine growth retardation (IUGR) (OR 0.48, 95% CI 0.31 to 0.72), gestational hypertension (OR 0.19, 95% CI 0.08 to 0.42), pre-eclampsia (OR 0.46, 95% CI 0.29 to 0.72). In contrast, a positive correlation was observed between full-term birth and HCQ use (OR 2.01, 95% CI 1.52 to 2.65). However, the result for disease flare exhibited high heterogeneity (p=0.01, I\n                      <jats:sup>2<\/jats:sup>\n                      =59%). In addition, publication bias was detected in the meta-analysis of full-term birth using the Egger\u2019s test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This meta-analysis offers a comprehensive assessment of the relationship between disease activity, pregnancy-related outcomes and HCQ use, providing supportive evidence for the therapeutic effectiveness of HCQ in pregnant women with SLE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42022374468.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/lupus-2024-001239","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T11:37:04Z","timestamp":1730288224000},"page":"e001239","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":26,"title":["Effect of hydroxychloroquine on pregnancy outcome in patients with SLE: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7675-2619","authenticated-orcid":false,"given":"Qingmiao","family":"Zhu","sequence":"first","affiliation":[{"name":"School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Wang","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qice","family":"Sun","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Xie","sequence":"additional","affiliation":[{"name":"Key Laboratory of Chinese medicine rheumatology of Zhejiang Province, Research Institute of Chinese Medical Clinical Foundation and Immunology, College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongqun","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory of Chinese medicine rheumatology of Zhejiang Province, Research Institute of Chinese Medical Clinical Foundation and Immunology, College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Yang","sequence":"additional","affiliation":[{"name":"The Third School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Song","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kepeng","family":"Yang","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5405-3509","authenticated-orcid":false,"given":"Ting","family":"Zhao","sequence":"additional","affiliation":[{"name":"Key Laboratory of Chinese medicine rheumatology of Zhejiang Province, Research Institute of Chinese Medical Clinical Foundation and Immunology, College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"2026061704350740000_11.2.e001239.1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223035"},{"key":"2026061704350740000_11.2.e001239.2","doi-asserted-by":"crossref","first-page":"102864","DOI":"10.1016\/j.jaut.2022.102864","article-title":"Pregnancy-related complications in systemic lupus erythematosus","volume":"132","author":"Tan","year":"2022","journal-title":"J Autoimmun"},{"key":"2026061704350740000_11.2.e001239.3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bpobgyn.2019.09.002","article-title":"Pregnancy and Systemic Lupus Erythematosus","volume":"64","author":"Petri","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2026061704350740000_11.2.e001239.4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209770"},{"key":"2026061704350740000_11.2.e001239.5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00393-020-00772-9","article-title":"Schwangerschaft bei Lupus erythematodes \u2013 ein Update","volume":"79","author":"Fischer-Betz","year":"2020","journal-title":"Z Rheumatol"},{"key":"2026061704350740000_11.2.e001239.6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/14740338.2017.1269168","article-title":"Hydroxychloroquine in systemic lupus erythematosus (SLE)","volume":"16","author":"Ponticelli","year":"2017","journal-title":"Expert Opin Drug Saf"},{"key":"2026061704350740000_11.2.e001239.7","first-page":"2165","article-title":"Systemic lupus erythematosus and pregnancy: A retrospective single-center study of 215 pregnancies from Portugal","volume":"30","author":"Braga","year":"2021","journal-title":"Lupus (Los Angel)"},{"key":"2026061704350740000_11.2.e001239.8","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1093\/rheumatology\/keab155","article-title":"Are remission and low disease activity state ideal targets for pregnancy planning in systemic lupus erythematosus? A multicentre study","volume":"60","author":"Tani","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2026061704350740000_11.2.e001239.9","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000651","article-title":"Hydroxychloroquine in the pregnancies of women with lupus: a meta-analysis of individual participant data","volume":"9","author":"Clowse","year":"2022","journal-title":"Lupus Sci Med"},{"key":"2026061704350740000_11.2.e001239.10","first-page":"1397","article-title":"Maternal and fetal outcomes of lupus pregnancies: A collective effort by Karnataka Rheumatologists","volume":"29","author":"Janardana","year":"2020","journal-title":"Lupus (Los Angel)"},{"key":"2026061704350740000_11.2.e001239.11","first-page":"1163","article-title":"Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: a meta-analysis","volume":"30","author":"Duan","year":"2021","journal-title":"Lupus (Los Angel)"},{"key":"2026061704350740000_11.2.e001239.12","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s10067-022-06462-y","article-title":"The use of hydroxychloroquine in pregnancy and its effect on perinatal outcomes in a population with autoimmune abnormalities","volume":"42","author":"Ye","year":"2023","journal-title":"Clin Rheumatol"},{"key":"2026061704350740000_11.2.e001239.13","doi-asserted-by":"crossref","unstructured":"Kalok A , Abdul Cader R , Indirayani I , et al . Pregnancy outcomes in systemic lupus erythematosus (SLE) women. Horm Mol Biol Clin Investig 2019;40. doi:10.1515\/hmbci-2019-0007","DOI":"10.1515\/hmbci-2019-0007"},{"key":"2026061704350740000_11.2.e001239.14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/25785826.2020.1868652","article-title":"Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine","volume":"44","author":"Canti","year":"2021","journal-title":"Immunol Med"},{"key":"2026061704350740000_11.2.e001239.15","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/BOR.0000000000000651","article-title":"Update on pregnancy complications in systemic lupus erythematosus","volume":"31","author":"Marder","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"2026061704350740000_11.2.e001239.16","first-page":"1384","article-title":"Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study","volume":"24","author":"Leroux","year":"2015","journal-title":"Lupus (Los Angel)"},{"key":"2026061704350740000_11.2.e001239.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2013.04.005"},{"key":"2026061704350740000_11.2.e001239.18","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12872"},{"key":"2026061704350740000_11.2.e001239.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.09.007"},{"key":"2026061704350740000_11.2.e001239.20","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.2174\/1381612826666200707132920","article-title":"The Role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases","volume":"26","author":"Martinez","year":"2020","journal-title":"Curr Pharm Des"},{"key":"2026061704350740000_11.2.e001239.21","doi-asserted-by":"crossref","first-page":"105143","DOI":"10.1016\/j.jbspin.2021.105143","article-title":"Hydroxychloroquine in systemic and autoimmune diseases: Where are we now?","volume":"88","author":"Dima","year":"2021","journal-title":"Joint Bone Spine"},{"key":"2026061704350740000_11.2.e001239.22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1055\/s-0040-1715140","article-title":"New Benefits of Hydroxychloroquine in Pregnant Women with Systemic Lupus Erythematosus: a Retrospective Study in a Tertiary Centre","volume":"42","author":"Abd Rahman","year":"2020","journal-title":"Rev Bras Ginecol Obstet"},{"key":"2026061704350740000_11.2.e001239.23","doi-asserted-by":"publisher","DOI":"10.1002\/art.22159"},{"key":"2026061704350740000_11.2.e001239.24","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1055\/s-0039-3402752","article-title":"Does Hydroxychloroquine Protect against Preeclampsia and Preterm Delivery in Systemic Lupus Erythematosus Pregnancies?","volume":"37","author":"Do","year":"2020","journal-title":"Am J Perinatol"},{"key":"2026061704350740000_11.2.e001239.25","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2810202","article-title":"Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births","volume":"2017","author":"Kroese","year":"2017","journal-title":"J Immunol Res"},{"key":"2026061704350740000_11.2.e001239.26","first-page":"722","article-title":"Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia","volume":"28","author":"Seo","year":"2019","journal-title":"Lupus (Los Angel)"},{"key":"2026061704350740000_11.2.e001239.27","first-page":"12","article-title":"Effect of Hydroxychloroquine and Liuwei Dihuang Wan in the treatment of systemic lupus erythematosus complicated with pregnancy","volume":"23","author":"Cao","year":"2012","journal-title":"Hainan Med J"},{"key":"2026061704350740000_11.2.e001239.28","unstructured":"Chen GL . A multicentre retrospective cohort study of pregnancy outcomes associated with systemic lupus erythematosus. Fujian Medical University, 2021."},{"key":"2026061704350740000_11.2.e001239.29","unstructured":"Deng RR . Analysis of pregnancy outcomes in pregnancies with systemic lupus erythematosus. Tianjin Medical University, 2017."},{"key":"2026061704350740000_11.2.e001239.30","first-page":"46","article-title":"Clinical observation of prednisone combined with hydroxychloroquine in the treatment of systemic lupus erythematosus during pregnancy","volume":"24","author":"Diao","year":"2016","journal-title":"Clin Res"},{"key":"2026061704350740000_11.2.e001239.31","first-page":"46","article-title":"Effects of hydroxychloroquine combined with prednisone on the pregnancy outcomes, blood lipid and neonatal Apgar levels in pregnant patients with systemic lupus erythematosus","volume":"28","author":"Wu","year":"2019","journal-title":"Chin J Hum Sex"},{"key":"2026061704350740000_11.2.e001239.32","first-page":"28","article-title":"Clinical effect of hydroxychloroquine combined with prednisone in the treatment of pregnancy with systemic lupus erythematosus","volume":"14","author":"Lin","year":"2021","journal-title":"Chin J Clin Rational Drug Use"},{"key":"2026061704350740000_11.2.e001239.33","first-page":"673","article-title":"Effect of prednisone combined with hydroxychloroquine in the treatment of systemic lupus erythematosus with pregnancy","volume":"58","author":"Liu","year":"2015","journal-title":"Ppl's Mil Surg"},{"key":"2026061704350740000_11.2.e001239.34","first-page":"84","article-title":"Clinical observation of prednisone combined with hydroxychloroquine in the treatment of systemic lupus erythematosus during pregnancy","volume":"10","author":"Liu","year":"2013","journal-title":"China Health Ind"},{"key":"2026061704350740000_11.2.e001239.35","first-page":"129","article-title":"Feasibility study of hydroxychloroquine adjuvant treatment of pregnancy complicated with systemic lupus erythematosus","volume":"27","author":"Zheng","year":"2015","journal-title":"Strait Pharm J"},{"key":"2026061704350740000_11.2.e001239.36","first-page":"153","article-title":"Clinical evaluation of prednisone and hydroxychloroquine in the treatment of systemic lupus erythematosus during pregnancy","volume":"16","author":"Wang","year":"2018","journal-title":"Chin Foreign Med Res"},{"key":"2026061704350740000_11.2.e001239.37","first-page":"1196","article-title":"The influences of hydroxychloroquine combined with hormone drug on outcomes of maternal and infant, serum IFN-\u03b3 and IL-10 levels of pregnant women with systemic lupus erythematosus","volume":"26","author":"Wang","year":"2018","journal-title":"Chin J Fam Plann"},{"key":"2026061704350740000_11.2.e001239.38","unstructured":"Wu MY . The Effect and Safety of Hydroxychloroquine in Pregnant Patient with Systemic Lupus Erythematosus. Central South University, 2014."},{"key":"2026061704350740000_11.2.e001239.39","first-page":"58","article-title":"Effect of prednisone combined with hydroxychloroquine in the treatment of systemic lupus erythematosus during pregnancy","volume":"17","author":"Zhang","year":"2019","journal-title":"Chin Foreign Med Res"},{"key":"2026061704350740000_11.2.e001239.40","first-page":"10","article-title":"The efficacy and safety of hydroxychloroquine sulfate on pregnancy outcomes in patients with system Lupus erythematosus","volume":"21","author":"Zhou","year":"2017","journal-title":"Chin J Rheumatol"},{"key":"2026061704350740000_11.2.e001239.41","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00404-021-06178-5","article-title":"Biochemical and clinical predictors in pregnant women with antiphospholipid syndrome and systemic lupus erythematosus: comprehensive update","volume":"304","author":"Li","year":"2021","journal-title":"Arch Gynecol Obstet"},{"key":"2026061704350740000_11.2.e001239.42","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jbspin.2018.03.006","article-title":"Hydroxychloroquine for the prevention of fetal growth restriction and prematurity in lupus pregnancy: a systematic review and meta-analysis","volume":"85","author":"Guillotin","year":"2018","journal-title":"Joint Bone Spine"},{"key":"2026061704350740000_11.2.e001239.43","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14131"},{"key":"2026061704350740000_11.2.e001239.44","first-page":"1819","article-title":"Aspirin for Prevention of Preeclampsia","volume":"77","author":"Atallah","year":"2017","journal-title":"Drugs (Abingdon Engl)"},{"key":"2026061704350740000_11.2.e001239.45","doi-asserted-by":"crossref","first-page":"S1108","DOI":"10.1016\/j.ajog.2020.08.045","article-title":"Prevention of preeclampsia with aspirin","volume":"226","author":"Rolnik","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"2026061704350740000_11.2.e001239.46","doi-asserted-by":"publisher","DOI":"10.1126\/science.705336"},{"key":"2026061704350740000_11.2.e001239.47","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-021-02699-1","article-title":"Preterm birth is strongly affected by the glucocorticoid dose during pregnancy in women complicated by systemic lupus erythematosus","volume":"24","author":"Shimada","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2026061704350740000_11.2.e001239.48","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000602","article-title":"Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomes","volume":"9","author":"Balevic","year":"2022","journal-title":"Lupus Sci Med"},{"key":"2026061704350740000_11.2.e001239.49","first-page":"57","article-title":"Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease","volume":"46","author":"Balevic","year":"2019","journal-title":"Implications for Maternal and Neonatal Outcomes J Rheumatol"},{"key":"2026061704350740000_11.2.e001239.50","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/acr.23263","article-title":"Contribution of Socioeconomic Status to Racial\/Ethnic Disparities in Adverse Pregnancy Outcomes Among Women With Systemic Lupus Erythematosus","volume":"70","author":"Kaplowitz","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2024-001239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T11:35:20Z","timestamp":1781696120000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2024-001239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,10,30]]},"published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1136\/lupus-2024-001239"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2024-001239","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}